Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members

Qingyan Fei1, Douglas W Ethell

  • 1Division of Biomedical Sciences, University of California Riverside, Riverside, California 92521-0121, USA.

Journal of Neurochemistry
|February 13, 2008
PubMed

Insights

Parkinson's disease involves neuron loss. This study reveals that paraquat and maneb toxins, individually activating Bak, synergize to trigger Bax-dependent cell death, offering new insights into Parkinson's pathology.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Parkinson's disease (PD) is characterized by dopaminergic neuron degeneration in the Substantia Nigra pars compacta.
  • Environmental toxins like paraquat (PQ) and MPTP induce selective dopaminergic neurodegeneration, contributing to sporadic PD.
  • Understanding the cell death mechanisms of combined toxins is crucial for PD research.

Purpose of the Study:

  • To elucidate the synergistic cell death mechanisms of paraquat (PQ) and maneb in dopaminergic neurons.
  • To investigate the roles of Bak and Bax in mediating apoptosis induced by PQ and maneb, individually and in combination.
  • To identify the molecular pathways underlying the switch from Bak-dependent to Bax-dependent cell death.

Main Methods:

  • Utilized siRNA knockdown of Bax and Bak to confirm their roles in cell death pathways.
  • Analyzed the expression of key apoptosis regulators, including Bak inhibitors (Bfl-1, Bcl-xL, Mcl-1) and Bax activators (Bik, Bim).
  • Investigated mitochondrial outer membrane permeabilization (MOMP) and apoptosis induction.

Main Results:

  • Individually, PQ and maneb induce Bak-dependent apoptosis.
  • Concurrently, PQ and maneb trigger Bax-dependent apoptosis, blocking the Bak pathway.
  • The combination treatment upregulates Bak inhibitors and increases Bax activators, promoting Bax-dependent MOMP and apoptosis.

Conclusions:

  • The combined exposure to PQ and maneb shifts the apoptotic pathway from Bak-dependence to Bax-dependence.
  • This synergistic effect involves the modulation of key Bcl-2 family proteins, including Bak inhibitors and Bax activators.
  • Findings provide critical insights into how combined environmental insults may contribute to Parkinson's disease pathogenesis.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...